low-molecular-weight heparins (Lovenox, Fragmin) for treating unstable angina and non-Q-wave MIs
December 1999
The American Heart Assoc and American College of Cardiology now recommend low-molecular-weight heparins (Lovenox, Fragmin) for treating unstable angina and non-Q-wave MIs.
They can be used as an alternative to unfractionated heparin.
In fact, Lovenox (enoxaparin) seems to be MORE effective than standard heparin for reducing the risk of MI and death.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote